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Abstract
The replacement of nucleosomal H2A with the histone variant H2A.Z is critical for regulating DNA-
mediated processes across eukaryotes and for early development of multicellular organisms. How
this variant performs these seemingly diverse roles has remained largely enigmatic. Here, we discuss
recent mechanistic insights that have begun to reveal how H2A.Z functions as a molecular rheostat
for gene control. We focus on specific examples in metazoans as a model for understanding how
H2A.Z integrates information from histone post-translational modifications, other histone variants,
and transcription factors (TFs) to regulate proper induction of gene expression programs in response
to cellular cues. Finally, we propose a general model of how H2A.Z incorporation regulates chromatin
states in diverse processes.
Introduction
Regulation of chromatin dynamics and accessibility is
critical for proper control of all DNA-mediated processes,
particularly in response to cellular cues. The replication-
independent incorporation of histone variants by specific
ATP-dependent chromatin remodeling complexes has
emerged as a critical mechanism for regulating DNA
repair, chromosome segregation, genomic stability, and
gene expression [1–3]. The highly conserved H2A-type
variant H2A.Z has garnered particular interest over the last
several years because it has essential but unknown roles in
early metazoan development [4,5]. Recent work demon-
strating that H2A.Z is necessary for the proper execution of
developmental programs during embryonic stem cell
(ESC) differentiation [6–8] as well as for regulating the
activation of gene expression patterns during muscle
differentiation, T cell activation, and hormone-mediated
gene activation [9–12] has led to a model whereby H2A.Z
functions tomediate gene induction in response to diverse
cellular cues.
Both in vitro and in vivo studies have shown that H2A.Z
incorporation can alter nucleosome structure and
dynamics, the activity of chromatin remodeling enzymes,
andhistonemodificationpatterns [2,13].H2A.Z is enriched
at the majority of transcription start sites (TSSs) of RNA
polymerase II (RNAPII)-regulated genes across eukaryotes,
including mammals as well as regulatory regions, such as
enhancers and boundary elements [7,8,14]. Intriguingly,
H2A.Z is enriched at both active and silent genes, yet how
H2A.Z influences gene expression in a context-dependent
manner has remained elusive. In this review, we highlight
recent work that reveals newmechanistic insights into how
H2A.Z acts as a molecular gatekeeper for RNAPII at
promoters and how H2A.Z integrates information from
histone post-translational modifications (PTMs), other
histone variants, and TFs to affect specific transcriptional
outcomes during development, tissue specification, and
immune- and hormone-mediated responses. Collectively,
these studies suggest that H2A.Z acts as a molecular
rheostat for gene control and serve as a paradigm for
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understanding its broader roles to regulate chromatin
states in response to environmental and genetic
perturbations.
Regulation of +1 nucleosome and RNA
polymerase II progression
H2A.Z is highly enriched at the promoter regions of a large
subset of genes across cell types, consistent with a role in
transcriptional regulation. Although the precise patterns of
enrichment differ slightly among eukaryotes, genome-
wide studies from yeast to human indicate that H2A.Z-
containing nucleosomes flank the nucleosome-depleted
region (NDR) at TSSs [9,15,16]. Why is H2A.Z incorpora-
tion at the TSS important for transcriptional regulation? In
vitro studies have demonstrated that the nucleosome
immediately downstream of the TSS (denoted +1 nucleo-
some) poses a sizeable barrier to transcription and can
direct the orientation of the pre-initiation complex (PICs)
and subsequent transcriptional elongation [17,18]. In
Drosophila, the +1 nucleosome obstructs RNAPII transit,
resulting in the increased stalling and backtracking of the
polymerase [19]. Notably, H2A.Z enrichment at the +1
nucleosome correlates with decreased RNAPII stalling,
suggesting that its incorporation reduces the high-energy
barrier to RNAPII progression. Consistent with this idea,
H2A.Z levels anti-correlate with nucleosome turnover,
indicating that H2A.Z incorporation at the +1 nucleosome
regulates productive elongation by facilitating H2A.Z/
H2B dimer loss without depletion of (H3-H4)2 tetramers.
These findings suggest that H2A.Z incorporation at the
+1 nucleosome regulates transcriptional output by mod-
ulating RNAPII kinetics and transcriptional elongation
(Figure 1). Given that Drosophila H2A.Z has features of
both H2A.Z and H2A.X (known as H2AvD) [20,21],
whether H2A.Z incorporation at the +1 nucleosome has
similar roles in other organisms remains an open question.
Moreover, whereas a large number of genes are regulated by
polymerasepausing inDrosophila, not allH2A.Z target genes
in other organisms are regulated in this manner [22]. In
mouse ESCs, H2A.Z is present at a large set of genesmarked
by histone 3 lysine 4 trimethylation (H3K4me3) nucleo-
somes that includeboth active genes aswell as poised, silent
developmental genes [6–8,14]. The poised genes harbor
H3K27me3, a repressive mark catalyzed by polycomb
repressive complex 2 (PRC2) and dramatically less paused
RNAPII [7,8,14,22]. Thus, how H2A.Z functions at the +1
nucleosome to mediate these contrasting transcriptional
outcomes will likely be influenced by other factors.
H2A.Z-associated post-translational modifications
correlate with transcriptional outcome
H2A.Z is highly conserved among eukaryotes and ubiqui-
tously expressed across cell types and its replication-
independent incorporation is critical for regulating diverse
transcriptional outcomes at a large number of RNAPII-
regulated promoters. Promoter nucleosome stability and
dynamics can be regulated by histone PTMs. Similar to
major type histones, variants are also subject to diverse
PTMs which are thought to function to recruit downstream
effectors, such as histonewriters, readers, or erasers to target
genes [23,24]. For example, amino-terminal acetylation of
H2A.Z (acH2A.Z) is strongly enriched at the 5’ end of active
gene promoters [8,14,25,26]. Whereas in Saccharomyces
cerevisiae, H2A.Z is acetylated by the ESA1 and NuA4
complexes [27,28], their mammalian counterparts have
not been clearly defined. Recent studies showed that the
bromodomain-containing protein Brd2 preferentially
associates with H2A.Z-containing nucleosomes at active
genes and that Brd2 recruitment is necessary for androgen
receptor-regulated gene activation [29] (Figure 2A). Brd2
has a higher affinity for H2A.Z nucleosomes compared to
canonical H2A, particularly in conjunction with nucleo-
somes that also harbor H4 amino-terminal acetylation
in vitro. H4 acetylation has been implicated in deconden-
sing higher-order chromatin structures and in mediating
an active chromatin state [30], suggesting that H4 acety-
lation marks the transition from a repressed state to an
active chromatin state. However, whether H4ac is sufficient
or whether additional mechanisms are necessary to drive
Figure 1. H2A.Z nucleosome composition at promoters
influences nucleosome stability and transcriptional state
(Top) The transition from homotypic to heterotypic H2A.Z nucleosomes
can regulate gene activation through regulation of transcription elongation.
(Bottom) H2A.Z nucleosomes can impact the stability of the +1
nucleosome and RNA polymerase II progression.
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Brd2 recruitment to target promoters in vivo is not clear.
Genome-wide localization studies revealed that acH2A.Z
is enriched at activated prostate cancer genes in androgen-
sensitive human prostate cancer cells (LNCaP) [26]. Given
that bromodomains are recruited to sites of action by
recognizing acetylated lysines [31], acH2A.Z may be an
additional determinant for Brd2 recruitment at these
regions. More broadly, Brd2 is a member of the BET
(bromodomain and extra terminal domain) family of
proteins that also includes Brd4, which has critical roles in
gene activation in ESCs and in cancer [32–36]. Thus, it will
be of interest to determine whether acH2A.Z facilitates
recruitment of BET proteins during gene activation in vivo.
In addition to active genes, H2A.Z is enriched at silent
genes that are poised for activation in ESCs. In mammals,
H2A.Z can be ubiquitinated at K120, K121, and K125
residues by the E3 ligase activity of the PRC1 component
Ring1b, suggesting a repressive role of this H2A.Z PTM
[14,37]. Consistent with this idea, H2A.Z monoubiqui-
tination (H2A.Zub) appears to demarcate facultative
heterochromatin [37]. Interestingly, loss of the H2A.Z
deubiquitinating enzyme USP10 results in a failure of
androgen-receptor target gene activation, suggesting that
the removal of this modification is necessary for gene
induction [38]. Recent reports showed that PRC1-
mediated ubiquitination of core H2A (H2Aub) impedes
RNAPII recruitment at bivalent genes [39] and may
facilitate PRC2 targeting and the establishment of
polycomb domain formation [40,41]. Moreover,
H2Aub stimulates PRC2 recruitment to chromatinized
templates and catalysis of H3K27me3 in vitro, suggesting
that H2Aub is a critical downstream effector of poly-
comb silencing [42]. Given that PRC1 catalyzes the
ubiquitination of both H2A and H2A.Z [14,39], we
speculate that H2A.Zub is also a key determinant for
Figure 2. H2A.Z regulates gene induction
(A) In response to androgen receptor (AR) signaling, H2A.Z allows binding of AR to its response elements, at both promoters and enhancers, and along with
acH4 recruits Brd2 and RNA polymerase II to mediate gene activation. (B) H2A.Z is enriched at both active and silent, poised genes in embryonic stem
cells. The effect of H2A.Z on transcription depends on the balance of both activating and repressive histone post-translational modifications as well as
H2A.Z-specific deposition and removal complexes in response to cellular cues.
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regulating RNAPII recruitment and polycomb domain
formation.
In mouse ESCs, acH2A.Z and H2A.Zub are co-enriched
with H3K27me3 nucleosomes, indicating that dually
modified H2A.Z (acH2A.Zub) is present at poised
developmental genes [14] (Figure 2B). One attractive
model is that H2A.Zub contributes to the recruitment of
PRC2 and reduces nucleosome accessibility (e.g. dimer
loss) at the +1 nucleosome, whereas acH2A.Z promotes
RNAPII progression perhaps through recruitment of BET
family members, known regulators of polymerase pause
release [43,44]. Notably, H2A.Z facilitates access to both
active and repressive complexes to chromatin in ESCs to
regulate the balance between self-renewal and differ-
entiation [8]. Thus, the balance of acH2A.Z and H2A.Zub
at promoters may be critical for regulating the induction
of gene expression programs in response to develop-
mental cues.
Regulation of H2A.Z incorporation is critical
for gene regulation
Although histone PTMs provide context-dependent
signals to regulate H2A.Z function at promoters, dissect-
ing how this variant is targeted to discrete genomic sites is
also important for understanding its regulatory roles. The
exchange of H2A for H2A.Z is catalyzed by ATP-
dependent complexes in a replication-independent
manner in all eukaryotes, namely the SWR1 complex
(SRCAP in mouse and human) as well as by p400/Tip60
in higher eukaryotes [45,46]. Notably, INO80, an ATP-
dependent remodeler known for its role in DNA repair,
has been implicated in transcription-dependent removal
of H2A.Z in yeast [47,48]. Whether INO80 functions
similarly in higher eukaryotes is yet to be determined.
Histone chaperones are additional factors that regulate
histone variant incorporation [49]. For example, the
metazoan-specific histone chaperone, ANP32E (acidic
nuclear phosphoprotein 32 kDa E), which is amember of
the p400 complex, regulates variant incorporation by
facilitating the removal of H2A.Z dimers as evidenced by
increased accumulation of H2A.Z at promoters and
enhancers in ANP32E knockout cells [50,51]. Together,
these studies suggest that the interplay between H2A.Z-
specific ATP-dependent remodelers and histone chaper-
ones is crucial for regulating H2A.Z incorporation.
Until recently, how H2A.Z exchange complexes are
targeted to specific sites remained largely unknown.
Evidence now suggests that SWR1 and INO80 complexes
may recognize NDRs to remodel H2A.Z at the +1
nucleosome by selective positioning of distinct compo-
nents of the remodeling complex around the NDR [52].
Biochemical analyses suggest that SRCAP and ANP32E
recognize specific features of H2A.Z that are divergent
from coreH2A, such as the C-terminala-helix to facilitate
the exchange reaction [50,53], providing an additional
mechanism for how remodelers distinguish between the
two histones. Recent work also highlights roles for
histone PTMs in proper histone exchange [46,48]. For
example, in contrast to its well-documented role in H2A.
Z deposition, yeast SRCAP (SWR-C) displays altered
substrate specificity in the presence of H3K56ac, leading
to the removal of H2A.Z dimers from chromatin [48]. In
human ESCs, H3K56ac is enriched at both active and
inactive genes that largely overlap targets of the core
pluripotency TFs OCT4, SOX2, and NANOG [54].
Notably, H3K56ac is redistributed to developmental
genes that are activated in response to retinoic acid
during ESC differentiation. Thus, H3K56ac and H2A.Z
may cross-talk to regulate H2A.Z dynamics and gene
expression across eukaryotes.
In addition to histone PTMs, H2A.Z incorporation
appears to be influenced by DNA methylation levels.
Studies in both plants and mammals suggest that H2A.Z
and DNA methylation are mutually antagonistic at
promoters and within gene bodies [55,56]. Consistent
with this idea, 5-aza 20-deoxycytidine-induced DNA
demethylation stimulates SRCAP-mediated H2A.Z incor-
poration, facilitating nucleosome depletion and gene
activation in cancer cells [57]. Although these studies
point to a model whereby H2A.Z incorporation is tar-
geted to discrete regions of the genome by a variety of
mechanisms, evidence also suggests that H2A.Z can be
randomly incorporated at low levels and that the removal
of H2A.Z is a key event for regulating chromatin states
[58,59]. Thus, a balance between the targeted deposition
and removal of H2A.Z is likely critical for maintaining
proper chromatin states.
H2A.Z nucleosome composition affects
chromatin dynamics
Modulating the number of H2A.Z copies in a nucleo-
some can also have consequences on nucleosome structure
and function. Early structural studies suggested that, owing
to steric clashes between the L1 loops of H2A.Z and
H2A, formation of a heterotypic H2A.Z nucleosome is
unlikely [60], but in vitro and in vivo evidence now indicates
that H2A.Z can form both heterotypic and homotypic
nucleosomes [16,61]. In vitro biochemical analyses showed
that two copies of H2A.Z (homotypic) result in a more
stable nucleosome that is refractory to RNAPII progression
[62,63]. However, homotypic H2A.Z is enriched at the
+1 nucleosome in Drosophila, which is thought to decrease
the energy barrier to RNAPII progression, and is depleted
downstream of paused polymerase [16]. In mouse
trophoblast cells, H2A.Z appears to be redistributed to
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heterochromatin (for example, telomeres) during G2/M,
resulting in a shift from homotypic to heterotypic H2A.Z
nucleosomes and to an expanded NDR at the TSS of active
H2A.Z genes [64]. Surprisingly, this transition from
homotypic to heterotypic H2A.Z nucleosomes during the
cell cycle does not appear to correlate with cell cycle-
dependent transcriptional changes. Thus, the consequence
of H2A.Z composition on transcription is highly complex
and likely depends on its levels at the TSS relative to gene
bodies as well as the presence of histone modifications or
other histone variants or both.
The incorporation of other histone variants with H2A.Z
can alter the functional properties of nucleosomes. H3.3
differs from major type H3 by only four or five amino
acids in metazoans yet displays distinct regulation and
biochemical properties. In mammalian cells, double-
variant nucleosomes containing H2A.Z and H3.3 mark
regions of dynamic chromatin regulation and are highly
salt-labile [65–67]. Moreover, in yeast, where non-
centromeric H3 is most similar to vertebrate H3.3, in
vitro reconstituted nucleosomes display release of H2A.Z
dimers in low salt [68,69]. Together, these findings
suggest a conserved mechanism in which H3.3 further
regulates the stability of the H2A.Z nucleosome. Nota-
bly, whereas H2A.Z facilitates intranucleosomal folding,
H3.3 counteracts the H2A.Z-mediated compaction of
nucleosomal arrays in vitro [70,71] and can relieve the
transcription repression caused by H2A.Z-containing
chromatin [71]. In ESCs, H3.3 depletion results in
reduced nucleosome turnover and an increase in PRC2
enrichment [6,7,72,73]. Conversely, mutation of the C-
terminal H2A.Z acidic patch to resemble core H2A leads
to an increase in H2A.Z dynamics, de-repression of
poised developmental genes, and increased H3.3 enrich-
ment in ESCs [7]. Together, these studies indicate that
H3.3 cooperates with H2A.Z to regulate nucleosome
stability, chromatin accessibility, and transcriptional
output. Future investigations to determine how the
balance between H3.3 and H2A.Z is regulated at specific
genomic locations are needed to understand how these
variants regulate global gene expression programs.
H2A.Z is a critical binding platform for
pioneer TFs
Given that TF binding is influenced by nucleosome
density and histone PTMs [69,74] and that H2A.Z
exhibits strong genetic interactions with TFs in yeast
[74], it is likely that H2A.Z also coordinates transcrip-
tional responses by modulating TF accessibility. Several
recent studies in mammals demonstrated that H2A.Z
nucleosomes are necessary for the recruitment of pioneer
TFs (Figure 3). Unlike classic TFs, pioneer TFs bind
nucleosomal DNA and remain bound to their sites
through mitosis, providing a level of epigenetic memory
[75]. Foxa2 is an example of a pioneer TF that has key
roles in development and transcriptional activation. In
ESCs, H2A.Z is required for the recruitment of Foxa2 to
promoters of genes activated during early endoderm
differentiation [76]. Moreover, the binding of Foxa2
to H2A.Z nucleosomes promotes the recruitment of
SWI/SNF and INO80 complexes, resulting in H2A.Z
removal and nucleosome depletion, establishing a plat-
form for the binding of other TFs. On the other hand,
loss of either H2A.Z or Foxa2 impairs gene induction and
differentiation. This work adds another layer to how
H2A.Z mechanistically regulates gene expression.
In addition to its requirement for regulating develop-
mental transitions, H2A.Z is necessary for the expression
of circadian-regulated genes by modulating TF binding.
CLOCK and BMAL1 are pioneer TFs that bind to
circadian clock-regulated genes to induce their expres-
sion in a temporally regulated manner [77]. Like binding
of Foxa2, binding of these TFs promotes gene activation
and the recruitment of RNAPII. Interestingly, CLOCK:
BMAL1 binding strongly correlates with cyclical changes
in H2A.Z occupancy and nucleosome depletion [78].
Using mouse livers at different time points in the light/
dark cycle, investigators demonstrated that H2A.Z-
enriched nucleosomes flank CLOCK-binding sites at
both promoters and intergenic regulatory regions.
Notably, H2A.Z levels oscillate on the basis of CLOCK:
BMAL1 binding. The cyclical binding of CLOCK:BMAL1
induces nucleosome depletion at promoters, allowing
additional TFs to gain access to DNA. Loss of BMAL1 in
mice results in a decreased H2A.Z levels and a higher
nucleosome occupancy at CLOCK-binding sites as well as
loss of circadian regulation, suggesting that H2A.Z is
necessary to maintain these sites in a highly plastic state.
Collectively, these studies reveal that H2A.Z provides a
crucial binding platform for pioneer TFs to facilitate precise
regulation of gene expression programs.
Concluding remarks
Since H2A.Z was first identified over 30 years ago, studies
have begun to reveal the many layers of regulation and
complex functions of H2A.Z in modulating chromatin
dynamics and gene expression. Recent studies have
uncovered many players involved in H2A.Z-mediated
transcriptional regulation, but how H2A.Z translates
upstream signals into diverse transcriptional outcomes
is still largely unknown. Although we have focused
largely on the roles of H2A.Z at promoters, H2A.Z also
appears to be enriched at a small subset of enhancers;
however, its roles in enhancer regulation are poorly
understood [7,8,14]. Overall levels of H2A.Z are lower
at enhancers compared with promoters, whereas H3.3
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displays the opposite trend [79]. Thus, the dynamic
interplay between H2A.Z and H3.3 at enhancers and
promoters may facilitate gene regulation. Consistent
with this idea, recent evidence supports the role of
H2A.Z in mediating higher-order chromatin interactions
between promoters and enhancers [80]. Additional
mechanistic studies are needed to understand how
histone variants contribute to these critical regulatory
interactions.
Insights into the function of H2A.Z in gene induction are
critical for understanding how H2A.Z functions in other
processes, such as DNA repair and genomic stability. For
example, p400-mediated H2A.Z incorporation during
double-strand break (DSB) repair stimulates an open
chromatin conformation, resulting in the formation of
an efficient chromatin template for DSB repair, albeit
through different effectors [81]. Interestingly, H2A.Z
acetylation and ubiquitylation are also hallmarks of
Figure 3. H2A.Z acts a scaffold for binding of chromatin remodelers and pioneer transcription factors
During endodermal differentiation, the pioneer transcription factor Foxa2 binds to H2A.Z nucleosomes, leading to the recruitment of chromatin
remodelers, nucleosome depletion, transcription factor binding, and subsequent gene activation.
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chromatin at DSBs, suggesting a general model by which
H2A.Z modulates chromatin in diverse DNA-mediated
processes. Given that H2A.Z has been implicated in the
activation of estrogen- and androgen-responsive genes in
models of breast and prostate cancer [11,38,82,83],
continued mechanistic studies into H2A.Z function will
be critical to fully understand how H2A.Z contributes to
development and disease.
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